Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES

FAST MONEY FEATURES

PollFast Money PollsFAST MONEY POLL
Get in the post game.  Respond to our "Question of the Day" right now.




Full ShowFull ShowFULL SHOWS
Missed an episode of Fast Money?  Watch the lastest show here.




Trade SchoolTRADE SCHOOL
Grab a pencil because school is in session and the Fast Money traders are teaching class.



PodcastFM PodcastsFAST MONEY PODCASTS
Download Fast Money onto your MP3 Player.




FM WIDGETFAST MONEY WIDGET
Grab this all-in-one application and get recaps of the show sent right to your desktop or blog.




ShopSHOP FOR FAST MONEY MERCHANDISE
Get your game on with Fast Money gear.




Wanna See Our PhotosFAST MONEY PHOTOS!
Check out our scrapbook.  These "pix" are guaranteed winners.




SignupNewsletterNEWSLETTER
Sign up and receive a recap email every Friday after the show!





FM Mobile AlertFAST MONEY MOBILE ALERTS
Get advanced information about the next Fast Money.



Fast Money DisclaimerFast Money BiosAbout Fast MoneyRapid RecapFast Money Home
Text Size
Jul.15
5:51 PM ET
Wednesday, 15 Jul 2009
Pops & Drops: American Express, Cadence Pharma...

Following are the day’s biggest winners and losers. Find out why shares of Cadence Pharma and American Express popped while Abbott Labs and Yum Brands dropped.

POPS (stocks that jumped higher)

Palm (PALM) popped 2%. The company still made gains despite news that Apple was blocking the Pre from iTunes. - I think the stock is still pretty solid, says Pete Najarian.

American Express (AXP) popped 12%. Rival Capital One said delinquency rates declined in June and charge-offs were lower than expected. - Jefferies has a $33 price target on this stock, adds Joe Terranova. I'm a buyer.

Oil Service Holdrs ETF (OIH) popped 4%. Bullish sentiment toward crude oil lifted this ETF. - Guy Adami told you to be a buyer at $90 and now it's around $98, reminds Karen Finerman.

Emerging Markets ETF (EEM) popped 5%. China stocks hit a 13-month high and Brazil stocks touched a 2 month high on higher commodities prices. - It seems that investors are chasing after this asset class, adds Tim Seymour.

Cadence Pharmaceuticals (CADX) popped 5%. The Food and Drug Administration assigned a priority review status for the company's painkiller Acetavance. - The pop might not be over just yet, speculates Pete Najarian.

Janus Capital (JNS) popped 2%. Reuters reported Franklin may be in talks to purchase the company in an all stock deal worth $13.50/share. - It's not the best name in the space, says Karen Finerman. Don't play it.

General Electric (GE) popped 5%. Barron’s reported that options traders are placing their bets on a gain in the stock.

DROPS (stocks that slid lower)

Abbott Labs (ABT) dropped 3%. The drug maker missed on revenues for the second quarter and gave a cautious outlook for the third quarter. - This company doesn't have enough diversification for me, reveals Joe Terranova.

Yum Brands (YUM) dropped 6%. Despite a stronger than expected earnings report an analyst at Jefferies wasn’t quite so positive. Jeff Farmer said the company’s double-digit growth in China isn’t sustainable.

Pops & Drops
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...




______________________________________________________
Got something to to say? Send us an e-mail at and your comment might be posted on the Rapid Recap! If you'd prefer to make a comment but not have it published on our website send your e-mail to .

© 2009 CNBC.com

Tools:
PrintEmailAdd This share icon
Next Post
  • digg share
ADD COMMENTS
Remaining characters


Current DateTime: 01:13:32 30 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 11:44:57 30 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 04:05:34 30 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 11:23:58 30 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters